Addus Homecare (NASDAQ:ADUS) Trading Up 5.5% After Analyst Upgrade

Addus Homecare Co. (NASDAQ:ADUS)’s share price was up 5.5% during mid-day trading on Tuesday after Sidoti raised their price target on the stock from $84.00 to $96.00. Sidoti currently has a buy rating on the stock. Addus Homecare traded as high as $82.86 and last traded at $80.90, approximately 177,605 shares were traded during trading. An increase of 64% from the average daily volume of 108,092 shares. The stock had previously closed at $76.71.

ADUS has been the topic of a number of other reports. Raymond James boosted their target price on Addus Homecare from $75.00 to $81.00 and gave the stock an “outperform” rating in a research report on Thursday, June 13th. BidaskClub raised Addus Homecare from a “hold” rating to a “buy” rating in a research report on Saturday, July 27th. Zacks Investment Research raised Addus Homecare from a “hold” rating to a “strong-buy” rating and set a $79.00 target price on the stock in a research report on Monday, May 13th. Finally, BMO Capital Markets started coverage on Addus Homecare in a research report on Thursday, June 27th. They set a “market perform” rating on the stock. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $79.89.

In other news, CFO Brian Poff sold 814 shares of Addus Homecare stock in a transaction on Friday, May 10th. The stock was sold at an average price of $67.96, for a total transaction of $55,319.44. Following the transaction, the chief financial officer now owns 18,241 shares in the company, valued at $1,239,658.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Mark L. First sold 440,000 shares of Addus Homecare stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $74.08, for a total value of $32,595,200.00. Following the transaction, the director now owns 19,151 shares in the company, valued at approximately $1,418,706.08. The disclosure for this sale can be found here. Insiders have sold 460,814 shares of company stock worth $34,061,919 in the last quarter. 20.10% of the stock is currently owned by corporate insiders.

Several hedge funds have recently modified their holdings of ADUS. Bank of New York Mellon Corp increased its position in shares of Addus Homecare by 117.8% in the fourth quarter. Bank of New York Mellon Corp now owns 120,855 shares of the company’s stock valued at $8,204,000 after buying an additional 65,356 shares in the last quarter. Northern Trust Corp lifted its position in shares of Addus Homecare by 0.5% during the 4th quarter. Northern Trust Corp now owns 144,750 shares of the company’s stock worth $9,825,000 after purchasing an additional 672 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Addus Homecare by 7.1% during the 4th quarter. Geode Capital Management LLC now owns 111,819 shares of the company’s stock worth $7,590,000 after purchasing an additional 7,384 shares during the last quarter. Bank of America Corp DE lifted its position in shares of Addus Homecare by 547.0% during the 4th quarter. Bank of America Corp DE now owns 21,928 shares of the company’s stock worth $1,490,000 after purchasing an additional 18,539 shares during the last quarter. Finally, Metropolitan Life Insurance Co. NY lifted its position in shares of Addus Homecare by 400.0% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 3,235 shares of the company’s stock worth $220,000 after purchasing an additional 2,588 shares during the last quarter. Institutional investors and hedge funds own 98.75% of the company’s stock.

The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.87 and a current ratio of 2.87. The firm has a market capitalization of $1.05 billion, a price-to-earnings ratio of 47.87, a price-to-earnings-growth ratio of 2.44 and a beta of -0.10. The company has a 50-day moving average price of $77.01.

Addus Homecare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, August 5th. The company reported $0.47 earnings per share for the quarter, hitting the consensus estimate of $0.47. Addus Homecare had a return on equity of 8.95% and a net margin of 3.20%. The business had revenue of $149.69 million during the quarter, compared to analysts’ expectations of $146.66 million. On average, research analysts forecast that Addus Homecare Co. will post 2.11 EPS for the current fiscal year.

Addus Homecare Company Profile (NASDAQ:ADUS)

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.

Featured Story: Strangles

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.